Observation time and the development of esophageal adenocarcinoma or its precursor lesions
| . | n* . | Person-years . | Median follow-up, y (range) . | No. events . |
|---|---|---|---|---|
| Cancer | 344 | 1,637 | 5.4 (0.2-8.9) | 38 |
| Aneuploidy | 309 | 1,467 | 5.5 (0.4-8.9) | 35 |
| Tetraploidy | 309 | 1,431 | 5.3 (0.2-8.9) | 42 |
| . | n* . | Person-years . | Median follow-up, y (range) . | No. events . |
|---|---|---|---|---|
| Cancer | 344 | 1,637 | 5.4 (0.2-8.9) | 38 |
| Aneuploidy | 309 | 1,467 | 5.5 (0.4-8.9) | 35 |
| Tetraploidy | 309 | 1,431 | 5.3 (0.2-8.9) | 42 |
Number of subjects without the outcome at baseline.